An update of the pharmacological treatment options for generalized myasthenia gravis in adults with anti–acetylcholine receptor antibodies.
Purpose This review aims to provide an update on current pharmacological agents for the management of generalized myasthenia gravis (MG). Summary MG is an autoimmune disease characterized by impaired neuromuscular transmission and muscle weakness. Most patients have autoimmune antibodies to the nico...
| Publicado en: | American Journal of Health-System Pharmacy Vol. 80; no. 11; pp. 652 - 663 |
|---|---|
| Autores principales: | , , , |
| Formato: | algorithm pictorial review tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Jun2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |